Riskpilot← Back to searchSign inGet full accessORIPATCH AS
ASActiveOrg 923723854Høvågveien 220, 4639 Kristiansand SManufacture of pharmaceutical preparations · NACE 2120Est. 20191 employees
Revenue 2024
NOK 1M
-1% vs 2023
EBITDA margin
-149.8%
-373% vs 2023
Equity ratio
11.7%
Financial strength
Net profit 2024
NOK -1,5M
-163% vs 2023
| Revenue | NOK 1M | -1% |
| EBITDA | NOK -1,5M | -373% |
| Net profit | NOK -1,5M | -163% |
| Total assets | NOK 695K | -59% |
| Equity | NOK 81K | -95% |
| Employees | 1 | — |
Legal name
ORIPATCH AS
Org number
923723854
Legal form
Aksjeselskap
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
30. oktober 2019
Share capital
NOK 51 488
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Forskning og utvikling av legemidler og medisinsk utstyr, samt hva herved står i forbindelse.
Address
Høvågveien 220, 4639 Kristiansand S
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 225 | 255 | 576 | 1 028 | 1 018 |
| Staff expenses | −0 | −0 | −0 | −268 | −563 | −459 |
| EBITDA | −8 | −1 | −261 | −824 | −322 | −1 525 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −8 | −1 | −261 | −824 | −322 | −1 525 |
| Net financials | 0 | 0 | 0 | 8 | −15 | 4 |
| Profit before tax | −8 | −1 | −261 | −816 | −337 | −1 521 |
| Tax | −3 | −0 | −57 | −180 | 240 | −0 |
| Net profit | −5 | −1 | −203 | −637 | −577 | −1 521 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 27 | 37 | 77 | 2 430 | 1 699 | 695 |
| Equity | 20 | 19 | −184 | 2 179 | 1 602 | 81 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 500 |
| Short-term debt | 8 | 18 | 261 | 251 | 97 | 113 |
| Total debt | 8 | 18 | 261 | 251 | 97 | 613 |
EBITDA margin
-149.8%
This company
15.8%
Market median
-1048% vs market
20192024
Equity ratio
11.7%
This company
38.2%
Market median
-69% vs market
20192024
Return on equity
-1872.1%
This company
18.4%
Market median
-10274% vs market
20192024
Net profit margin
-149.4%
This company
8.1%
Market median
-1944% vs market
20192024
Asset turnover
1.47×
This company
1.12×
Market median
+31% vs market
20192024
Debt / equity
7.55×
This company
0.62×
Market median
-1118% vs market
20192024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2023 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Skuthe Holding As | Company | 60.0% | 60.0% | 2024 |
Skabe As | Company | 20.0% | 20.0% | 2024 |
Tvedt & Co As | Company | 16.8% | 16.8% | 2024 |
Quaestor Forvaltning As | Company | 3.2% | 3.2% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Skabe As
ORIPATCH AS Board members of ORIPATCH AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Cathrine Aardal Skuthe | Board of Directors | 0 companies |
| Jostein Skuthe | Chairman | 0 companies |
| Jarleif Tvedt | Board of Directors | 0 companies |
| Kjetil Henriksen | Board of Directors | 0 companies |
| Ralf Schmidt | Board of Directors | 0 companies |